Aciclovir Sodium Naprod Life Sciences | Special Precautions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing Local Product Insert

Full Prescribing Info

Special Precautions

General: The recommended dosage, frequency, and length of treatment should not be exceeded. Administration of Aciclovir sodium Intravenous Infusion B.P. by intravenous infusion must be accompanied by adequate hydration. Since maximum urine concentration occurs within the first 2 hours following infusion, particular attention should be given to establishing sufficient urine flow during that period in order to prevent precipitation in renal tubules. Recommended urine output is >500 ml per gram of drug infused. In patients with encephalitis, the recommended hydration should be balanced by the risk of cerebral edema. When dosage adjustments are required, they should be based on estimated creatinine clearance. Approximately 1% of patients receiving intravenous Aciclovir have manifested eccephalopathic changes characterized by either lethargy, obtundation, tremors, confusion, hallucinations, agitation, seizures, or coma.

Aciclovir Sodium Naprod Life Sciences Special Precautions

aciclovir

Manufacturer:

Naprod Life Sciences

Distributor:

Atlanta Medicare